title: Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
abstract: A generic drug can save a hospital as much one year as it spent on the brand-name version of that drug the previous year. Yet hospitals, for various reasons, are sitting on the bench as the 'generic vs. brand name' war between pharmaceutical companies goes on.
authors.forename: C
authors.initials: C
authors.lastname: Becker
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000191:economics; D017046:Cost Savings; D016527:Drug Costs / Q000331:legislation & jurisprudence* / Q000639:trends; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics*; D017754:Group Purchasing; D006801:Humans; D006993:Hypnotics and Sedatives / Q000191:economics; D008874:Midazolam / Q000191:economics; D017239:Paclitaxel / Q000191:economics; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D010607:Pharmacy Service, Hospital / Q000191:economics*; D014481:United States
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D016568:Drugs, Generic; D006993:Hypnotics and Sedatives; D017239:Paclitaxel; D008874:Midazolam